Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present BioDelivery Sciences International, Inc. (NASDAQ: BDSI).

Full DD Report for BDSI

You must become a subscriber to view this report.


Recent News from (NASDAQ: BDSI)

BioDelivery Sciences Announces Further Significant Expanded Preferred Coverage For BELBUCA®
More than 100 million Covered Lives Now Have Preferred Access to BELBUCA  RALEIGH, N.C., Nov. 01, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing commercial-stage specialty pharmaceutical company dedicated to patients living with...
Source: GlobeNewswire
Date: November, 01 2018 16:10
BioDelivery Sciences Announces Changes to its Executive Leadership Team
James Vollins joins the Company in role of General Counsel, Chief Compliance Officer, and Corporate Secretary Ernest De Paolantonio, Chief Financial Officer announces plan to retire by mid-2019 Scott Plesha, President takes on additional role of Chief Commercial Officer RALEIGH...
Source: GlobeNewswire
Date: October, 29 2018 08:30
Senate vote approaches on bill to combat opioid crisis
The Senate will vote next week on the Opioid Crisis Response Act, a lineup of over 70 proposals to fight the opioid crisis following the 50 opioid-related bills that passed the House in June. More news on: Endo International plc, Mallinckrodt PLC, INDIVIOR PLC ADR, Healthcare stocks news...
Source: SeekingAlpha
Date: September, 07 2018 12:48
BioDelivery Sciences (BDSI) Presents At Rodman & Renshaw.C. Wainwright 20th Annual Global Investment Conference - Slideshow
The following slide deck was published by BioDelivery Sciences International, Inc. in conjunction with this Read more ...
Source: SeekingAlpha
Date: September, 07 2018 12:35
FDA updates on multifaceted plan to combat opioid crisis
In a statement , FDA Commissioner Scott Gottlieb, M.D. outlines the FDA's many initiatives aimed at addressing the U.S. opioid crisis. Key points: More news on: Endo International plc, Mallinckrodt PLC, INDIVIOR PLC ADR, Healthcare stocks news, Read more ...
Source: SeekingAlpha
Date: August, 29 2018 12:44
FDA clamps down on opioid-peddling websites
The FDA has sent Warning Letters to four additional online networks operating a total of 21 websites for illegally promoting opioids to Americans. The action follows the issuance of 13 Warning Letters to more than 70 websites over the summer. More news on: Endo International plc, Mallinc...
Source: SeekingAlpha
Date: August, 28 2018 10:57
Factors of Influence in 2018, Key Indicators and Opportunity within Aurora Cannabis, Canopy Growth, MobileIron, Sangamo Therapeutics, BioDelivery Sciences International, and First Solar - New Research Emphasizes Economic Growth
NEW YORK, Aug. 23, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Aurora Cannabis Inc. (OTC:ACBFF), Canopy Growth Corporation (NYSE:CGC), M...
Source: GlobeNewswire
Date: August, 23 2018 08:10
FDA awards contract to develop guidelines for opioid prescribing
The FDA has awarded a contract to the National Academies of Sciences, Engineering and Medicine to help advance the development of evidence-based guidelines to help physicians prescribe opioid pain meds in a more appropriate way. More news on: Endo International plc, Mallinckrodt PLC, IND...
Source: SeekingAlpha
Date: August, 22 2018 11:16
BioDelivery Sciences to Present at the Rodman & Renshaw 20th Annual Global Investment Conference
RALEIGH, N.C., Aug. 21, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc., (NASDAQ:BDSI), a leading commercial specialty pharmaceutical company dedicated to patients living with chronic pain, today announced that Herm Cukier, Chief Executive Officer will present at the Rodma...
Source: GlobeNewswire
Date: August, 21 2018 08:00
White House proposing cuts in opioid production
Aimed at fighting the U.S. opioid crisis, the Trump administration is proposing production cuts in the most-abused compounds, oxycodone, hydrocodone, oxymorphone, hydromorphone, morphine and fentanyl, by 10% next year. More news on: Endo International plc, Mallinckrodt PLC, Johnson &...
Source: SeekingAlpha
Date: August, 16 2018 15:24

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-183.463.263.493.22507,964
2018-12-173.593.3953.623.36499,633
2018-12-143.653.5453.753.45442,558
2018-12-133.603.733.773.521,042,156
2018-12-123.553.583.603.51190,631

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-1896,186176,31554.5535Short
2018-12-1742,504102,40941.5042Short
2018-12-14104,517138,82575.2869Short
2018-12-13103,821772,13413.4460Cover
2018-12-1238,09680,16447.5226Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on BDSI.


About BioDelivery Sciences International, Inc. (NASDAQ: BDSI)

Logo for BioDelivery Sciences International, Inc. (NASDAQ: BDSI)

Not available

 

Contact Information

 

 

Current Management

  • Mark A. Sirgo / President, CEO
  • James A. McNulty / CFO, Secretary
  • Francis E. O Donnell Jr. / Chairman

Current Share Structure

  • Market Cap: $119,821,721 - 05/14/2018
  • Issue and Outstanding: 58,449,620 - 03/13/2018

 


Recent Filings from (NASDAQ: BDSI)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 17 2018
Prospectus filed under Rule 424(b)(3)
Filing Type: 424B3Filing Source: edgar
Filing Date: May, 17 2018
Free Writing Prospectus
Filing Type: FWPFiling Source: edgar
Filing Date: May, 17 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 11 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 10 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 08 2018
Additional proxy soliciting materials - definitive
Filing Type: DEFA14AFiling Source: edgar
Filing Date: May, 03 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 03 2018
Amendment to a SC 13D filing
Filing Type: SC 13D/AFiling Source: edgar
Filing Date: May, 01 2018
Filing Type: CT ORDERFiling Source: edgar
Filing Date: April, 18 2018

 

 


Daily Technical Chart for (NASDAQ: BDSI)

Daily Technical Chart for (NASDAQ: BDSI)


Stay tuned for daily updates and more on (NASDAQ: BDSI)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: BDSI)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in BDSI is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of BDSI and does not buy, sell, or trade any shares of BDSI. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/